HHS plans new FDA deputy commissioner roles for technology and drugs, sources say
The Department of Health and Human Services is planning to appoint deputy commissioners for technology and drugs at the FDA, creating new roles at the agency, CNBC has learned. Like existing deputy commissioner roles, the two new positions would report into Trump's pick for FDA commissioner, Heidi Overton, who still needs to be confirmed by the Senate.
HHS moves to tighten oversight of food ingredients as safety concerns mount
The U.S. Department of Health and Human Services proposed requiring companies to notify the Food & Drug Administration when they determine an ingredient is "generally recognized as safe." HHS and the USDA also said they submitted the government's first proposed ultra-processed foods definition for final review.
Harte Hanks Teams Up With Reddy to Revolutionize Customer Care Using AI-Driven Solutions
CHELMSFORD, MA / ACCESSWIRE / December 10, 2024 / Harte Hanks, Inc. (NASDAQ:HHS), the 101-year-old Massachusetts-based global customer experience company, today announced it's collaborating with Reddy, a contact center coaching and training platform that uses AI to help businesses automate and optimize their contact centers. Reddy is an all-in-one coaching platform powered by AI.
Harte Hanks, Inc. (HHS) Q3 2024 Earnings Call Transcript
Harte Hanks, Inc. (NASDAQ:HHS ) Q3 2024 Earnings Call Transcript November 14, 2024 4:30 PM ET Company Participants Tom Baumann - FNK, Investor Relations Kirk Davis - Chief Executive Officer David Garrison - Chief Financial Officer Conference Call Participants Operator Good afternoon. And welcome to the Harte Hanks Third Quarter 2024 Earnings Call.
Harte-Hanks (HHS) Q3 Earnings and Revenues Top Estimates
Harte-Hanks (HHS) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of $0.10 per share. This compares to earnings of $0.08 per share a year ago.
Harte Hanks Reports Third Quarter 2024 Results
CHELMSFORD, MA / ACCESSWIRE / November 14, 2024 / Harte Hanks, Inc. (NASDAQ:HHS), a leading global customer experience company focused on bringing companies closer to customers for over 100 years, today announced financial results for the third quarter ended September 30, 2024. Kirk Davis, Chief Executive Officer, stated: "In Q3, we continued to focus on improving our sales execution.
Harte-Hanks (HHS) Flat As Market Gains: What You Should Know
Harte-Hanks (HHS) concluded the recent trading session at $6.98, signifying no movement from its prior day's close.
Harte-Hanks (HHS) Stock Falls Amid Market Uptick: What Investors Need to Know
Harte-Hanks (HHS) closed the most recent trading day at $7.30, moving -1.35% from the previous trading session.
Harte-Hanks (HHS) Stock Falls Amid Market Uptick: What Investors Need to Know
In the most recent trading session, Harte-Hanks (HHS) closed at $7.30, indicating a -0.41% shift from the previous trading day.
Harte-Hanks (HHS) Stock Falls Amid Market Uptick: What Investors Need to Know
In the latest trading session, Harte-Hanks (HHS) closed at $7.31, marking a -0.41% move from the previous day.
Harte-Hanks (HHS) Rises Higher Than Market: Key Facts
In the latest trading session, Harte-Hanks (HHS) closed at $7.44, marking a +1.64% move from the previous day.
Harte-Hanks (HHS) Beats Stock Market Upswing: What Investors Need to Know
In the most recent trading session, Harte-Hanks (HHS) closed at $7.54, indicating a +0.94% shift from the previous trading day.
